PTHLH and breast carcinoma: In the PyMT-MMTV (mouse mammary tumor virus-polyoma middle T antigen) model of breast carcinoma where mice spontaneously develop mammary tumors, Cre-loxP-mediated Pthlh ablation delays primary tumor initiation and inhibits tumor progression (68).